US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27
AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and founder and managing director Hartley Atkinson believes it’s only going to get better as the growing Oz-based multinational pharmaceutical compan...
Market Cap $18.52M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.58pm 14/04/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 3.7¢ | 200000 | 0 | 3.9¢ | 30000 | |
Directors & Senior Management
| Mr. Adrian Paul Byass | Independent Non-Executive Director |
| Mr. Andrew Robert Mune Dinning | Executive Chairman, MD & CEO |
| Mr. John V. Hamilton | Founder & VP of Exploration |
| Mr. Lawrence Simon Jackson | Independent Non-Executive Director |
| Mr. Lui Evangelista | CFO & Company Secretary |
| Mr. Michael Andrew Bohm | Independent Non-Executive Director |
| Mr. Paul R. Schmiede | Vice President of Corporate Development |
Data source: ADVFN